Literature DB >> 10869522

Renin-angiotensin-aldosterone system and myocardial fibrosis.

C G Brilla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10869522     DOI： 10.1016/s0008-6363(00)00092-4

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  27 in total

1.  Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.

Authors:  Modar Kassan; Maria Galán; Megan Partyka; Zubaida Saifudeen; Daniel Henrion; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

2.  Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses.

Authors:  Peng Zhang; Jialin Su; Michelle E King; Angel E Maldonado; Cindy Park; Ulrike Mende
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

Review 3.  Hypertrophy to failure: what goes wrong with the fibers of the heart?

Authors:  S K Maulik; S Mishra
Journal:  Indian Heart J       Date:  2015-03-14

Review 4.  Diastolic heart failure in the elderly and the potential role of aldosterone antagonists.

Authors:  Ashwani Kumar; Gary Meyerrose; Vineeta Sood; Chanwit Roongsritong
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

Review 6.  Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance.

Authors:  Andrea Barison; Chrysanthos Grigoratos; Giancarlo Todiere; Giovanni Donato Aquaro
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

7.  The regulatory role of AT 1 receptor on activated HSCs in hepatic fibrogenesis:effects of RAS inhibitors on hepatic fibrosis induced by CCl(4).

Authors:  Hong-Shan Wei; Han-Ming Lu; Ding-Guo Li; Yu-Tao Zhan; Zhi-Rong Wang; Xin Huang; Ji-Lin Cheng; Qin-Fang Xu
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

8.  An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.

Authors:  Nobuya Kurikawa; Miwa Suga; Shoko Kuroda; Keisuke Yamada; Hirokazu Ishikawa
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

9.  The effect of enalapril on the cardiac remodelling in ovariectomized spontaneously hypertensive rats.

Authors:  Wellington V Santos; Leila M M Pereira; Carlos A Mandarim-de-Lacerda
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

10.  Comparative study of three angiotensin II type 1 receptor antagonists in preventing liver fibrosis in diabetic rats: stereology, histopathology, and electron microscopy.

Authors:  Sare Sipal; Zekai Halici; Ilhami Kiki; Beyzagul Polat; Abdulmecit Albayrak; Fatih Albayrak; Emre Karakus; Selina Aksak; Berna Ozturk; Cemal Gundogdu
Journal:  J Mol Histol       Date:  2012-08-26       Impact factor: 2.611
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.